Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Buy
115,957
+717
+0.6% +$78.9K 0.08% 205
2026
Q1
$12.1M Buy
115,240
+15,584
+16% +$1.83M 0.09% 194
2025
Q4
$12.4M Buy
99,656
+24,031
+32% +$2.86M 0.09% 170
2025
Q3
$9.07M Buy
75,625
+1,574
+2% +$166K 0.07% 207
2025
Q2
$6.8M Buy
74,051
+2,817
+4% +$257K 0.06% 260
2025
Q1
$6.27M Buy
71,234
+2,705
+4% +$266K 0.06% 250
2024
Q4
$6.34M Buy
68,529
+9,314
+16% +$896K 0.06% 253
2024
Q3
$5.49M Buy
59,215
+1,936
+3% +$163K 0.05% 285
2024
Q2
$4.29M Buy
+57,279
New +$4.57M 0.04% 326

Other funds holding CRH

Xponance's CRH Position: Q2 2026 in Review

Xponance increased its CRH (CRH) stake by 0.62% in Q2 2026, buying an estimated $78.9K and bringing the position to 115,957 shares worth $12.4M. The position accounts for 0.08% of the portfolio, ranked #205.

Xponance first reported a position in CRH in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.4M in Q4 2025. 1,025 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Xponance held 115,957 shares of CRH worth $12.4M as of Q2 2026.
  • Xponance bought 717 CRH shares in Q2 2026, an estimated $78.9K.
  • CRH made up 0.08% of Xponance's portfolio in Q2 2026, its #205 holding.
  • Xponance first reported a position in CRH in Q2 2024 and has held it in 9 quarters since.
  • Xponance's CRH position peaked at $12.4M in Q4 2025.
  • 1,025 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.